|
HY-P1012A-25mg
|
MedChemexpress LLC
|
[Sar9,Met(O2)11]-Substance P (TFA) [CAS 2828433-10-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1012A-5mg
|
MedChemexpress LLC
|
[Sar9,Met(O2)11]-Substance P (TFA) [CAS 2828433-10-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1012-1mg
|
MedChemexpress LLC
|
[Sar9,Met(O2)11]-Substance P [CAS 110880-55-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1012-10mg
|
MedChemexpress LLC
|
[Sar9,Met(O2)11]-Substance P [CAS 110880-55-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1012-25mg
|
MedChemexpress LLC
|
[Sar9,Met(O2)11]-Substance P [CAS 110880-55-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1012-5mg
|
MedChemexpress LLC
|
[Sar9,Met(O2)11]-Substance P [CAS 110880-55-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1738-1mg
|
MedChemexpress LLC
|
[Sar9] Substance P [CAS 77128-75-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1738-10mg
|
MedChemexpress LLC
|
[Sar9] Substance P [CAS 77128-75-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1738-5mg
|
MedChemexpress LLC
|
[Sar9] Substance P [CAS 77128-75-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-N7813-25mg
|
MedChemexpress LLC
|
1,2-Dipalmitoyl-3-oleoylglycerol [CAS 1867-91-0]
|
|
|
|
|
HY-W045998-100mg
|
MedChemexpress LLC
|
1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose [CAS 75096-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-W045998-50mg
|
MedChemexpress LLC
|
1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose [CAS 75096-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-144016-10mg
|
MedChemexpress LLC
|
16:0 EPC (chloride) [CAS 328250-18-6]
|
|
|
|
|
HY-W587733-5mg
|
MedChemexpress LLC
|
17Alpha,20Beta-Dihydroxy-4-pregnen-3-one [CAS 1662-06-2]
|
|
|
|
|
HY-104064-10mg
|
MedChemexpress LLC
|
1A-116 [CAS 1430208-73-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-104064-100mg
|
MedChemexpress LLC
|
1A-116 [CAS 1430208-73-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-104064-25mg
|
MedChemexpress LLC
|
1A-116 [CAS 1430208-73-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-104064-5mg
|
MedChemexpress LLC
|
1A-116 [CAS 1430208-73-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-104064-50mg
|
MedChemexpress LLC
|
1A-116 [CAS 1430208-73-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-104064-1mL
|
MedChemexpress LLC
|
1A-116 [CAS 1430208-73-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-136592-1mg
|
MedChemexpress LLC
|
1-Hydroxy-ibuprofen [CAS 53949-53-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-136592-5mg
|
MedChemexpress LLC
|
1-Hydroxy-ibuprofen [CAS 53949-53-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-W009141-100mg
|
MedChemexpress LLC
|
1-Monopalmitin [CAS 542-44-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W009141-250mg
|
MedChemexpress LLC
|
1-Monopalmitin [CAS 542-44-9]
|
|
Cancer-programmed cell death
|
|
|
HY-133948-25mg
|
MedChemexpress LLC
|
1-Monopalmitolein [CAS 37515-61-0]
|
|
|
|
